Search hospitals

>

Connecticut

>

Hartford

Hartford Hospital

Claim this profile

Hartford, Connecticut 06105

Global Leader in Breast Cancer

Global Leader in Ovarian Cancer

Conducts research for Fallopian Tube Cancer

Conducts research for Lung Cancer

Conducts research for Heart Failure

468 reported clinical trials

54 medical researchers

Photo of Hartford Hospital in HartfordPhoto of Hartford Hospital in HartfordPhoto of Hartford Hospital in Hartford

Summary

Hartford Hospital is a medical facility located in Hartford, Connecticut. This center is recognized for care of Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Lung Cancer, Heart Failure and other specialties. Hartford Hospital is involved with conducting 468 clinical trials across 622 conditions. There are 54 research doctors associated with this hospital, such as Charles Rutter, MD, Wylie Hosmer, MD, Robert Hagberg, MD, and Ahmad Daher, MD.

Area of expertise

1

Breast Cancer

Global Leader

Hartford Hospital has run 49 trials for Breast Cancer. Some of their research focus areas include:

HER2 positive
HER2 negative
ER positive
2

Ovarian Cancer

Global Leader

Hartford Hospital has run 41 trials for Ovarian Cancer. Some of their research focus areas include:

BRCA1 positive
Stage IV
Stage III

Top PIs

Clinical Trials running at Hartford Hospital

Lung Cancer

Breast Cancer

Ovarian Cancer

Bladder Cancer

Breast cancer

Pancreatic Cancer

Cancer

Multiple Myeloma

Heart Failure

Esophageal cancer

Image of trial facility.

Ceralasertib + Durvalumab

for Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Image of trial facility.

Durvalumab

for Lung Cancer

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.

Recruiting

2 awards

Phase 3

8 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Hartford Hospital?

Where is Hartford Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Hartford Hospital accept?

What awards or recognition has Hartford Hospital received?